DE69534619D1 - Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke - Google Patents

Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke

Info

Publication number
DE69534619D1
DE69534619D1 DE69534619T DE69534619T DE69534619D1 DE 69534619 D1 DE69534619 D1 DE 69534619D1 DE 69534619 T DE69534619 T DE 69534619T DE 69534619 T DE69534619 T DE 69534619T DE 69534619 D1 DE69534619 D1 DE 69534619D1
Authority
DE
Germany
Prior art keywords
joint
normal
information
aggrecan
normal aggrecan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69534619T
Other languages
English (en)
Other versions
DE69534619T2 (de
Inventor
Satosi Miyauti
Katuyuki Horie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Publication of DE69534619D1 publication Critical patent/DE69534619D1/de
Application granted granted Critical
Publication of DE69534619T2 publication Critical patent/DE69534619T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4722—Proteoglycans, e.g. aggreccan
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Peptides Or Proteins (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
DE69534619T 1994-02-19 1995-02-17 Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke Expired - Lifetime DE69534619T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5973994 1994-02-19
JP5973994 1994-02-19
PCT/JP1995/000220 WO1995022765A1 (fr) 1994-02-19 1995-02-17 Procede de dosage de l'aglycane normal, trousse de dosage et procede d'evaluation des informations relatives aux articulations

Publications (2)

Publication Number Publication Date
DE69534619D1 true DE69534619D1 (de) 2005-12-22
DE69534619T2 DE69534619T2 (de) 2006-07-13

Family

ID=13121899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534619T Expired - Lifetime DE69534619T2 (de) 1994-02-19 1995-02-17 Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke

Country Status (7)

Country Link
US (1) US5948692A (de)
EP (1) EP0745850B1 (de)
JP (1) JP3694894B2 (de)
AT (1) ATE310247T1 (de)
AU (1) AU705059B2 (de)
DE (1) DE69534619T2 (de)
WO (1) WO1995022765A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589755B1 (en) * 1996-08-15 2003-07-08 Novartis Ag Assay for quantifying arthritic conditions
US5869273A (en) * 1996-09-13 1999-02-09 Glyko, Inc. Chondroitin sulfate as a marker of bone resorption
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
US7005274B1 (en) 1999-09-15 2006-02-28 Migenix Corp. Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
US6705930B2 (en) * 2000-01-28 2004-03-16 Lam Research Corporation System and method for polishing and planarizing semiconductor wafers using reduced surface area polishing pads and variable partial pad-wafer overlapping techniques
US6904123B2 (en) * 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7545964B2 (en) * 2000-08-29 2009-06-09 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
ATE440536T1 (de) 2001-05-25 2009-09-15 Imaging Therapeutics Inc Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2003041635A2 (en) * 2001-09-24 2003-05-22 Mount Sinai School Of Medicine Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
US7840247B2 (en) 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
EP1605824A2 (de) 2003-03-25 2005-12-21 Imaging Therapeutics, Inc. Verfahren zur kompensation der bildgebenden technik bei der bearbeitung von röntgenaufnahmen
US8290564B2 (en) * 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
WO2005027732A2 (en) * 2003-09-19 2005-03-31 Imaging Therapeutics, Inc. Method for bone structure prognosis and simulated bone remodeling
EP1789924A2 (de) 2004-09-16 2007-05-30 Imaging Therapeutics, Inc. System und verfahren zur vorhersage von zukünftigen brüchen
US7273756B2 (en) * 2004-10-01 2007-09-25 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US20070082409A1 (en) * 2005-09-15 2007-04-12 The Regents Of The University Of Michigan Method and apparatus for measuring cartilage condition biomarkers
WO2007045661A1 (en) * 2005-10-20 2007-04-26 Nordic Bioscience Diagnostics A/S Detection or quantification of aggrecan and its fragments
JP4991847B2 (ja) * 2006-05-09 2012-08-01 ザ ユニバーシティ オブ ブリティッシュ コロンビア 溶解したタンパク質関節炎マーカー
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage
EP3418397B1 (de) 2012-01-24 2020-10-07 CD Diagnostics, Inc. System zum nachweis einer infektion in der synovialflüssigkeit
JP2018151206A (ja) * 2017-03-10 2018-09-27 一丸ファルコス株式会社 プロテオグリカン分析方法
EP3623816A1 (de) * 2018-09-12 2020-03-18 GLX Analytix ApS Glx-abgeleitete moleküldetektion
JP2020165937A (ja) * 2019-03-29 2020-10-08 国立大学法人弘前大学 プロテオグリカンの測定方法、評価方法および測定用キット

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1160566A (en) * 1980-04-25 1984-01-17 Harald Gallati Immunological determination method
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US5185245A (en) * 1989-02-24 1993-02-09 Thomas Jefferson University Immumoassays and kit for detection of proteoglycans
US5032281A (en) * 1989-08-09 1991-07-16 Daicel Chemical Industries, Ltd. Separating membrane and separation method

Also Published As

Publication number Publication date
EP0745850A1 (de) 1996-12-04
JP3694894B2 (ja) 2005-09-14
WO1995022765A1 (fr) 1995-08-24
EP0745850A4 (de) 2003-05-28
AU1717795A (en) 1995-09-04
ATE310247T1 (de) 2005-12-15
AU705059B2 (en) 1999-05-13
DE69534619T2 (de) 2006-07-13
US5948692A (en) 1999-09-07
EP0745850B1 (de) 2005-11-16

Similar Documents

Publication Publication Date Title
DE69534619D1 (de) Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke
AU690972B2 (en) Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements
Paterson et al. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer
EP0805215A3 (de) Diagnostische Methoden und Proben
DE502005005132D1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
CA2218008A1 (en) Use of thermochromic liquid crystals in reflectometry based diagnostic methods
Fex et al. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.
ATE312349T1 (de) Differentielle diagnose von neurodegeneration
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
ES2101802T3 (es) Ensayo para determinar los niveles de igf-i, igf-ii y gh libres en liquidos corporales.
ATE401342T1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
DE69941627D1 (de) Für krebs
US5185245A (en) Immumoassays and kit for detection of proteoglycans
DE69607176D1 (de) Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
DE602004025636D1 (de) Methode zur Beurteilung von rheumatoider Arthritis durch Bestimmung von Anti-CCP und Interleukin 6
Laurell Electrophoresis, specific protein assays, or both in measurement of plasma proteins?
ATE258310T1 (de) Testverfahren für collagenpeptid
DE69736336D1 (de) Verfahren zur messung von blutersatzstoffen
KR960705211A (ko) 체액내 bpi의 정량 방법(method for quantifying bpi in body fluids)
Pugia et al. Clinical utility of a rapid test for uristatin
DE69414871D1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
Bowles et al. Changes in serum bone-specific alkaline phosphatase following tibial fracture
FI990380A (fi) Diagnostinen ja seulontamenetelmä
DE59808639D1 (de) Verfahren zur bestimmung von schilddrüsen-autoantikörpern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition